COMP <GO>
PDEX vs UTMD // DIVIDEND YIELD & FCF PAYOUT SAFETY
Pro-Dex Inc. (NASDAQ) VS. Utah Medical Products Inc. (NASDAQ) • 15-METRIC TALLY: PDEX 3
— UTMD 7
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: UTMD
LAST: $61.60 (-2.52%) • MKT CAP: $199.2M
dividend-safety
0.00%
LAST: $66.80 (-2.96%) • MKT CAP: $212.7M
dividend-safety
1.87%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PDEX VS. UTMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PDEX | UTMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 29.30% | 57.10% | -27.80 | UTMD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 23.20% | 26.90% | -3.70 | UTMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.5x | 10.8x | +5.70 | UTMD | /valuation <GO> |
| Free Cash Flow Yield | -1.47% | 6.73% | -8.20 | UTMD | /fcf-yield <GO> |
| Operating Margin | 16.10% | 29.60% | -13.50 | UTMD | /operating-margins <GO> |
| Net Profit Margin | 13.50% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 23.70% | -5.80% | +29.50 | PDEX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 1.87% | -1.87 | UTMD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.08 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 4/9 | +1.00 | PDEX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.5 | 30.1 | +8.40 | PDEX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.6x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $199.2M | $212.7M | -$13.5M | UTMD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PDEX REV | UTMD REV | PDEX GROSS % | UTMD GROSS % | PDEX FCF | UTMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $66.6M | $38.5M | 29.3% | 57.1% | -$2.9M | $14.3M |
| FY 2024 | $53.8M | $40.9M | 27.0% | 59.0% | $6.2M | $14.6M |
| FY 2023 | $46.1M | $50.2M | — | — | $5.5M | $22.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PDEX // BETA —
UTMD // BETA —